Pharsight

Testim patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8178518 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7608608 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7608610 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US8063029 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7608605 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7608607 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7608609 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7935690 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7608606 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(11 months ago)

US7320968 AUXILIUM PHARMS LLC Pharmaceutical composition
Jan, 2025

(9 months from now)

Testim is owned by Auxilium Pharms Llc.

Testim contains Testosterone.

Testim has a total of 10 drug patents out of which 9 drug patents have expired.

Expired drug patents of Testim are:

  • US8178518
  • US7608608
  • US7608610
  • US8063029
  • US7608605
  • US7608607
  • US7608609
  • US7935690
  • US7608606

Testim was authorised for market use on 31 October, 2002.

Testim is available in gel;transdermal dosage forms.

Testim can be used as method for administration of testosterone.

The generics of Testim are possible to be released after 18 January, 2025.

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 31 October, 2002

Treatment: Method for administration of testosterone

Dosage: GEL;TRANSDERMAL

How can I launch a generic of TESTIM before it's drug patent expiration?
More Information on Dosage

TESTIM family patents

Family Patents